fluorouracil has been researched along with lewis x antigen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashley, J; Billups, C; Douglas, L; Houghton, JA; Mihalik, R; Petak, I; Schwartzberg, LS; Shope, S; Stewart, C; Tan, M; Tauer, K; Tillman, DM; Turner, PK; Weir, A | 1 |
Iinuma, N; Ishizone, S; Koide, N; Maruta, F; Miyagawa, S; Nakayama, J; Yanagisawa, Y | 1 |
Bhartiya, D; Kapoor, S; Nimkar, H; Shaikh, A | 1 |
1 trial(s) available for fluorouracil and lewis x antigen
Article | Year |
---|---|
Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Colorectal Neoplasms; Dose-Response Relationship, Drug; fas Receptor; Female; Flow Cytometry; Fluorouracil; Follow-Up Studies; Humans; Interferon-gamma; Leucovorin; Lewis X Antigen; Male; Middle Aged; Models, Biological; Signal Transduction; Time Factors; Tumor Cells, Cultured; Up-Regulation | 2002 |
2 other study(ies) available for fluorouracil and lewis x antigen
Article | Year |
---|---|
Modified Irinotecan/5FU/Leucovorin therapy in advanced colorectal cancer and predicting therapeutic efficacy by expression of tumor-related enzymes.
Topics: Adenocarcinoma; Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Lewis X Antigen; Male; Middle Aged; Oligosaccharides; Orotate Phosphoribosyltransferase; Prognosis; Sialyl Lewis X Antigen; Survival Rate; Thymidine Phosphorylase; Thymidylate Synthase; Vitamin B Complex | 2007 |
Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells.
Topics: Animals; Ataxin-1; Bone Marrow Cells; Cell Cycle; Cell Differentiation; Cell Size; Chromosomal Proteins, Non-Histone; Fluorouracil; Follicle Stimulating Hormone; Gene Expression; Hematopoiesis; Hematopoietic Stem Cells; Immunophenotyping; Leukocyte Common Antigens; Lewis X Antigen; Membrane Proteins; Mice; Nanog Homeobox Protein; Octamer Transcription Factor-3; Pluripotent Stem Cells; Proliferating Cell Nuclear Antigen; Proteins; Receptors, FSH | 2016 |